Sustainability Report

Overview

The report presents Glaukos' 2024 sustainability program, including the U.S. launch of iDose TR and an FDA New Drug Application submission for next-generation Epioxa therapy. It reports 995 employees, 45 community service events and over 730 volunteer hours. Environmental metrics include 523.3 MT CO2e of Scope 1 emissions, 2,535.3 MT CO2e of Scope 2 emissions, and a reported 57% renewable energy share. The report also describes Board oversight of sustainability and completed environmental goals.

Document

Report type: Sustainability Report
Class: Dedicated
Scope: Full report
Fiscal year: 2024
Period: 1 January 2024 – 31 December 2024
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP
Other

Ratings

GRI level

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services